Luigi Quintieri

1.3k total citations
53 papers, 1.0k citations indexed

About

Luigi Quintieri is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Luigi Quintieri has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Oncology and 14 papers in Pharmacology. Recurrent topics in Luigi Quintieri's work include Pharmacogenetics and Drug Metabolism (14 papers), Cancer therapeutics and mechanisms (8 papers) and Glutathione Transferases and Polymorphisms (7 papers). Luigi Quintieri is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Cancer therapeutics and mechanisms (8 papers) and Glutathione Transferases and Polymorphisms (7 papers). Luigi Quintieri collaborates with scholars based in Italy, United States and United Kingdom. Luigi Quintieri's co-authors include Maura Floreani, Pietro Palatini, Antonio Rosato, Paolo Ruzza, Carlo Riccardo Rossi, Marianna Fantin, Alberto Nassi, Paola Zanovello, Eleonora Napoli and Cristina Geroni and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Luigi Quintieri

52 papers receiving 1.0k citations

Peers

Luigi Quintieri
Pengcheng Wang United States
Joon‐Seok Choi South Korea
Nam‐Pyo Cho South Korea
Luigi Quintieri
Citations per year, relative to Luigi Quintieri Luigi Quintieri (= 1×) peers Zhixia Qiu

Countries citing papers authored by Luigi Quintieri

Since Specialization
Citations

This map shows the geographic impact of Luigi Quintieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Quintieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Quintieri more than expected).

Fields of papers citing papers by Luigi Quintieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Quintieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Quintieri. The network helps show where Luigi Quintieri may publish in the future.

Co-authorship network of co-authors of Luigi Quintieri

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Quintieri. A scholar is included among the top collaborators of Luigi Quintieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Quintieri. Luigi Quintieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Leonardi, Andrea, Luigi Quintieri, I Jáuregui, et al.. (2024). Allergic Conjunctivitis Management: Update on Ophthalmic Solutions. Current Allergy and Asthma Reports. 24(7). 347–360. 12 indexed citations
3.
Poggesi, Italo, et al.. (2024). A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6. Journal of Pharmacological and Toxicological Methods. 127. 107516–107516. 1 indexed citations
4.
Carpanese, Debora, Valentina Rossi, Luigi Quintieri, et al.. (2023). Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations. International Journal of Pharmaceutics. 649. 123643–123643. 5 indexed citations
5.
Piazza, Francesco, et al.. (2022). Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia. Frontiers in Oncology. 11. 801124–801124. 2 indexed citations
6.
Rotili, Dante, Anastasia De Luca, Stefano Tomassi, et al.. (2020). Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment. Biochemical Pharmacology. 178. 114060–114060. 8 indexed citations
7.
Bortolozzi, Roberta, Davide Carta, Elena Mattiuzzo, et al.. (2019). Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones. European Journal of Medicinal Chemistry. 178. 297–314. 15 indexed citations
8.
Quintieri, Luigi, et al.. (2014). Metabolic effects of antiangiogenic drugs in tumors: Therapeutic implications. Biochemical Pharmacology. 89(2). 162–170. 18 indexed citations
9.
Quintieri, Luigi, Pietro Palatini, Stefano Moro, & Maura Floreani. (2011). Inhibition of Cytochrome P450 2C8-mediated Drug Metabolism by the Flavonoid Diosmetin. Drug Metabolism and Pharmacokinetics. 26(6). 559–568. 22 indexed citations
10.
Quintieri, Luigi, et al.. (2010). Flavonoids Diosmetin and Hesperetin are Potent Inhibitors of Cytochrome P450 2C9-mediated Drug Metabolism in vitro. Drug Metabolism and Pharmacokinetics. 25(5). 466–476. 33 indexed citations
11.
Ruzza, Paolo, Antonio Rosato, Carlo Riccardo Rossi, Maura Floreani, & Luigi Quintieri. (2009). Glutathione Transferases as Targets for Cancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 9(7). 763–777. 74 indexed citations
12.
Orlando, R., et al.. (2008). Irreversible CYP3A Inhibition Accompanied by Plasma Protein–Binding Displacement: A Comparative Analysis in Subjects With Normal and Impaired Liver Function. Clinical Pharmacology & Therapeutics. 85(3). 319–326. 20 indexed citations
13.
Floreani, Maura, et al.. (2008). Carteolol, a non-conventional partial agonist of β1-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at α1-adrenoceptors. European Journal of Pharmacology. 590(1-3). 269–275. 4 indexed citations
14.
Quintieri, Luigi, et al.. (2007). Identification of Molecular Determinants of Tumor Sensitivity and Resistance to Anticancer Drugs. Advances in experimental medicine and biology. 593. 95–104. 39 indexed citations
15.
Geroni, Cristina, Maria Antonietta Sabatino, Dario Ballinari, et al.. (2006). Nemorubicin: A doxorubicin-like structure with a novel mechanism of action different from anthracyclines. Cancer Research. 66. 904–904. 2 indexed citations
16.
Fantin, Marianna, Luigi Quintieri, Erzsébet Kúsz, et al.. (2006). Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. European Journal of Pharmacology. 535(1-3). 301–309. 26 indexed citations
17.
Floreani, Maura, Guglielmina Froldi, Luigi Quintieri, et al.. (2005). In Vitro Evidence That Carteolol Is a Nonconventional Partial Agonist of Guinea Pig Cardiac β1-Adrenoceptors: A Comparison with Xamoterol. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1386–1395. 5 indexed citations
18.
Rossi, Carlo Riccardo, Mirto Foletto, Simone Mocellin, et al.. (2004). Hyperthermic Isolated Perfusion with Low-Dose TNFα and Doxorubicin in Patients with Locally Advanced Soft Tissue Limb Sarcomas. Journal of Chemotherapy. 16(sup5). 58–61. 7 indexed citations
19.
Rossi, Carlo Riccardo, Simone Mocellin, Pierluigi Pilati, et al.. (2003). Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surgical Oncology Clinics of North America. 12(3). 781–794. 39 indexed citations
20.
Vízler, Csaba, Antonio Rosato, Francesca Calderazzo, et al.. (1998). Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity. British Journal of Cancer. 77(4). 656–662. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026